Clinical Trial Update: Curcumin Supplement in Nonalcoholic Fatty Liver Patients [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial assessment of curcumin supplement in patients with type 2 diabetes and nonalcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: National Nutrition and Food Technology Institute | Conditions: Type 2 Diabetes, Nonalcoholic Fatty Liver | Phase 2, Phase 3 | Status: COMPLETED